查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1424051

抗寄生蟲藥市場、份額、規模、趨勢、產業分析報告：按類型、給藥途徑、分銷管道、地區、細分市場預測，2024-2032

Antiparasitic Drugs Market Share, Size, Trends, Industry Analysis Report, By Type (Antiprotozoals, Anthelmintics, Others); By Route of Administration; By Distribution Channel; By Region; Segment Forecast, 2024- 2032
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，到 2032 年，全球抗寄生蟲藥物市場預計將達到 382 億美元。 該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

發展中地區的新興市場為抗寄生蟲藥物市場提供了巨大機會。 醫療基礎設施的改善和意識的提高正在推動對寄生蟲感染有效治療的需求。 由於這些地區的感染率較高，製藥公司正在推出方便且負擔得起的解決方案，並建立策略聯盟以進入和擴張市場。

標靶治療是抗寄生蟲藥物市場的一個重要機會，它提供精確和個人化的治療，以提高療效並最大限度地減少副作用。 利用分子理解的進步，這些治療針對特定的寄生蟲，並提供創新的解決方案來改善患者的治療結果。 投資此類針對性方法研發的製藥公司可望引領市場。 這項策略性措施擴大了治療選擇，同時解決了抗藥性的挑戰，並符合抗寄生蟲藥物開發中個人化醫療的發展。

臨床試驗在塑造抗寄生蟲藥物市場方面發揮著至關重要的作用。 除了驗證安全性和有效性之外，製藥公司還透過參與嚴格的臨床試驗來確立自己的創新者地位。 成功的臨床試驗不僅能獲得監管部門的批准，還能建立可信度並獲得競爭優勢。 這種參與增強了醫療保健專業人員之間的信任，並有助於市場成長。 此外，此類臨床試驗將擴大可用治療方案的範圍，滿足對抗寄生蟲感染不斷變化的需求，並確保市場的持續擴張。

簡化的監管途徑、加速的審批和支持性框架為製藥創新創造了有利的環境。 這使得公司能夠將新型抗寄生蟲藥物快速推向市場並滿足重要的醫療保健需求。 監管機構和行業利益相關者之間的合作將實現高效的流程並促進及時的市場准入。 創新解決方案的鼓勵加上加速的監管框架正在推動抗寄生蟲藥物市場的持續成長。

抗寄生蟲藥物市場報告重點

2023年，由於蠕蟲感染的流行、全球健康活動和意識的提高，驅蟲藥行業佔據了較大的市場份額。

2023年，由於快速、直接的反應以及在醫院的廣泛使用，注射劑領域佔據了很大的市場份額。

2023 年，醫院藥局業務由於醫療機構內的患者可以輕鬆取得而佔據了很大的收入份額。

2023年，由於寄生蟲感染的流行、監管環境和研發，北美地區主導了全球市場。

該市場由具有全球影響力的市場參與者主導，例如拜耳公司、Cipla Limited、F. Hoffmann-La Roche Ltd.、葛蘭素史克、Ipca Laboratories Ltd.、Merck &Co、Viatris 和 Novartis，競爭很激烈。

目錄

第1章簡介

第 2 章執行摘要

第3章研究方法

第4章全球抗寄生蟲藥物市場洞察

  • 抗寄生蟲藥市場－通路概況
  • 抗寄生蟲藥物市場動態
    • 推動者和機會
      • 全球健康措施預計將刺激產品需求
      • 寄生蟲感染的流行預計將推動抗寄生蟲藥物市場的成長
    • 抑制因素和挑戰
      • 監理挑戰可能會阻礙市場成長
  • PESTEL 分析
  • 抗寄生蟲藥市場通路趨勢
  • 價值鏈分析
  • COVID-19 感染的影響分析

第五章全球抗寄生蟲藥物市場，依類型

  • 主要發現
  • 簡介
  • 抗原蟲藥
  • 驅蟲藥
  • 其他

第 6 章全球抗寄生蟲藥物市場（依給藥途徑）

  • 主要發現
  • 簡介
  • 本地
  • 口頭
  • 注射

第 7 章全球抗寄生蟲藥物市場（按分銷管道）

  • 主要發現
  • 簡介
  • 零售藥局
  • 醫院藥房
  • 其他

第 8 章全球抗寄生蟲藥物市場（按地區）

  • 主要發現
  • 簡介
    • 抗寄生蟲藥物市場評估，地區，2019-2032
  • 抗寄生藥物市場 - 北美
    • 北美：2019-2032 年抗寄生蟲藥物市場（按類型）
    • 北美：抗寄生蟲藥物市場，依通路劃分，2019-2032 年
    • 北美：2019-2032 年抗寄生蟲藥物市場（依給藥途徑）
    • 抗寄生藥物市場 - 美國
    • 抗寄生藥物市場 - 加拿大
  • 抗寄生藥物市場 - 歐洲
    • 歐洲：2019-2032 年抗寄生蟲藥物市場（按類型）
    • 歐洲：抗寄生蟲藥物市場，依通路劃分，2019-2032 年
    • 歐洲：2019-2032 年抗寄生蟲藥物市場（依給藥途徑）
    • 抗寄生藥物市場 - 英國
    • 抗寄生藥物市場 - 法國
    • 抗寄生藥物市場 - 德國
    • 抗寄生藥物市場 - 義大利
    • 抗寄生藥物市場 - 西班牙
    • 抗寄生藥物市場 - 荷蘭
    • 抗寄生藥物市場 - 俄羅斯
  • 抗寄生蟲藥物市場 - 亞太地區
    • 亞太地區：2019-2032 年抗寄生蟲藥物市場（按類型）
    • 亞太地區：抗寄生蟲藥物市場，依通路劃分，2019-2032 年
    • 亞太地區：抗寄生蟲藥物市場（依給藥途徑），2019-2032 年
    • 抗寄生藥物市場 - 中國
    • 抗寄生藥物市場 - 印度
    • 抗寄生藥物市場 - 馬來西亞
    • 抗寄生藥物市場 - 日本
    • 抗寄生藥物市場 - 印度尼西亞
    • 抗寄生藥物市場 - 韓國
  • 抗寄生蟲藥物市場 - 中東和非洲
    • 中東和非洲：2019-2032 年抗寄生蟲藥物市場（按類型）
    • 中東和非洲：抗寄生蟲藥物市場，按分銷管道劃分，2019-2032 年
    • 中東和非洲：2019-2032 年抗寄生蟲藥物市場（依給藥途徑）
    • 抗寄生蟲藥物市場 - 沙烏地阿拉伯
    • 抗寄生蟲藥物市場 - 阿拉伯聯合大公國
    • 抗寄生藥物市場 - 以色列
    • 抗寄生藥物市場 - 南非
  • 抗寄生藥物市場 - 拉丁美洲
    • 拉丁美洲：2019-2032 年抗寄生蟲藥物市場（按類型）
    • 拉丁美洲：抗寄生蟲藥物市場，依通路劃分，2019-2032 年
    • 拉丁美洲：2019-2032 年抗寄生蟲藥物市場（依給藥途徑）
    • 抗寄生藥物市場 - 墨西哥
    • 抗寄生藥物市場 - 巴西
    • 抗寄生藥物市場 - 阿根廷

第9章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協議/揭露

第10章公司簡介

  • AstraZeneca
  • Bayer AG
  • Cipla Limited
  • Dr. Reddy's Laboratories
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline
  • Ipca Laboratories Ltd
  • Lupin Pharmaceuticals
  • Merck & Co.
  • Novartis
  • Pfizer
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Viatris
  • Zydus Group
Product Code: PM4409

The global Antiparasitic Drugs market size is expected to reach USD 38.20 billion by 2032, according to a new study by Polaris Market Research. The report "Antiparasitic Drugs Market Share, Size, Trends, Industry Analysis Report, By Type (Antiprotozoals, Anthelmintics, Others); By Route of Administration; By Distribution Channel; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Emerging markets in developing regions offer prime opportunities for the Antiparasitic Drugs Market. Improved healthcare infrastructure and heightened awareness drive demand for effective treatments against parasitic infections. With higher infection rates in these regions, pharmaceutical companies introduce accessible and affordable solutions, establishing strategic collaborations for market entry and expansion.

Targeted therapies present a pivotal opportunity in the antiparasitic drugs market, offering precise, personalized treatment for enhanced efficacy and minimized side effects. Leveraging advancements in molecular understanding, these therapies focus on specific parasites, providing innovative solutions with improved patient outcomes. Pharmaceutical companies investing in research and development of such targeted approaches position themselves for market leadership. This strategic move addresses the challenges of drug resistance while expanding treatment options, aligning with the evolving landscape of personalized medicine in antiparasitic drug development.

Clinical trials play a pivotal role in shaping the antiparasitic drugs market. Beyond validating safety and efficacy, participation in rigorous trials positions pharmaceutical companies as innovators. Successful trials not only secure regulatory approvals but also establish credibility, gaining a competitive edge. This engagement fosters confidence among healthcare professionals, contributing to market growth. Furthermore, these trials broaden the spectrum of available treatment options, meeting evolving needs in the fight against parasitic infections and ensuring sustained market expansion.

Streamlined regulatory pathways, expedited approvals, and supportive frameworks create a conducive environment for pharmaceutical innovation. This backing allows companies to swiftly bring novel antiparasitic drugs to market, addressing critical healthcare needs. Collaborative efforts between regulatory bodies and industry players enable efficient processes, fostering timely market entry. The encouragement of innovative solutions, coupled with responsive regulatory frameworks, positions the antiparasitic drugs Market for sustained growth.

Antiparasitic Drugs Market Report Highlights

In 2023, the Anthelmintics segment accounted for significant market share owing to prevalence of helminthic infections, global health initiatives, and increased awareness.

In 2023, the injectable segment accounted for significant market share owing to rapid and direct response, and wide use in hospitals.

In 2023, the hospital pharmacy segment held significant revenue share owing to easy access for patients within healthcare institutions.

In 2023, North America region dominated the global market due to prevalence of parasitic infections, regulatory environment, and research and development.

The market is highly competitive owing to the existence of market players with a global presence, including Bayer AG, Cipla Limited, F. Hoffmann-La Roche Ltd., GlaxoSmithKline, Ipca Laboratories Ltd, Merck & Co., Viatris, and Novartis among others.

Polaris Market Research has segmented the Antiparasitic Drugs market report based on type, route of administration, distribution channel, and region:

Antiparasitic Drugs, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Antiprotozoals
  • Anthelmintics
  • Others

Antiparasitic Drugs, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

  • Topical
  • Oral
  • Injectable

Antiparasitic Drugs, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Retail Pharmacy
  • Hospital Pharmacy
  • Others

Antiparasitic Drugs, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Netherlands
  • Spain
  • Russia
  • Asia Pacific
  • Japan
  • China
  • India
  • Malaysia
  • Indonesia
  • South Korea
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Antiparasitic Drugs Market Insights

  • 4.1. Antiparasitic Drugs Market - Distribution Channel Snapshot
  • 4.2. Antiparasitic Drugs Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Global health initiatives are projected to spur the product demand
      • 4.2.1.2. Prevalence of parasitic infections is expected to drive antiparasitic drugs market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Regulatory challenges are likely to impede the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Antiparasitic Drugs Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Antiparasitic Drugs Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • 5.3. Antiprotozoals
    • 5.3.1. Global Antiparasitic Drugs Market, by Antiprotozoals, by Region, 2019-2032 (USD Billion)
  • 5.4. Anthelmintics
    • 5.4.1. Global Antiparasitic Drugs Market, by Anthelmintics, by Region, 2019-2032 (USD Billion)
  • 5.5. Others
    • 5.5.1. Global Antiparasitic Drugs Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Antiparasitic Drugs Market, by Route of Administration

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 6.3. Topical
    • 6.3.1. Global Antiparasitic Drugs Market, by Topical, by Region, 2019-2032 (USD Billion)
  • 6.4. Oral
    • 6.4.1. Global Antiparasitic Drugs Market, by Oral, by Region, 2019-2032 (USD Billion)
  • 6.5. Injectable
    • 6.5.1. Global Antiparasitic Drugs Market, by Injectable, by Region, 2019-2032 (USD Billion)

7. Global Antiparasitic Drugs Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 7.3. Retail Pharmacy
    • 7.3.1. Global Antiparasitic Drugs Market, by Retail Pharmacy, By Region, 2019-2032 (USD Billion)
  • 7.4. Hospital Pharmacy
    • 7.4.1. Global Antiparasitic Drugs Market, by Hospital Pharmacy, By Region, 2019-2032 (USD Billion)
  • 7.5. Others
    • 7.5.1. Global Antiparasitic Drugs Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Antiparasitic Drugs Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Antiparasitic Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Antiparasitic Drugs Market - North America
    • 8.3.1. North America: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.3. North America: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.3.4. Antiparasitic Drugs Market - U.S.
      • 8.3.4.1. U.S.: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.3.5. Antiparasitic Drugs Market - Canada
      • 8.3.5.1. Canada: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 8.4. Antiparasitic Drugs Market - Europe
    • 8.4.1. Europe: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.4. Antiparasitic Drugs Market - UK
      • 8.4.4.1. UK: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.5. Antiparasitic Drugs Market - France
      • 8.4.5.1. France: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.6. Antiparasitic Drugs Market - Germany
      • 8.4.6.1. Germany: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.7. Antiparasitic Drugs Market - Italy
      • 8.4.7.1. Italy: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.8. Antiparasitic Drugs Market - Spain
      • 8.4.8.1. Spain: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.9. Antiparasitic Drugs Market - Netherlands
      • 8.4.9.1. Netherlands: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.10. Antiparasitic Drugs Market - Russia
      • 8.4.10.1. Russia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 8.5. Antiparasitic Drugs Market - Asia Pacific
    • 8.5.1. Asia Pacific: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.4. Antiparasitic Drugs Market - China
      • 8.5.4.1. China: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.5. Antiparasitic Drugs Market - India
      • 8.5.5.1. India: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.6. Antiparasitic Drugs Market - Malaysia
      • 8.5.6.1. Malaysia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.7. Antiparasitic Drugs Market - Japan
      • 8.5.7.1. Japan: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.8. Antiparasitic Drugs Market - Indonesia
      • 8.5.8.1. Indonesia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.9. Antiparasitic Drugs Market - South Korea
      • 8.5.9.1. South Korea: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 8.6. Antiparasitic Drugs Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.6.4. Antiparasitic Drugs Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.6.5. Antiparasitic Drugs Market - UAE
      • 8.6.5.1. UAE: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.6.6. Antiparasitic Drugs Market - Israel
      • 8.6.6.1. Israel: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.6.7. Antiparasitic Drugs Market - South Africa
      • 8.6.7.1. South Africa: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 8.7. Antiparasitic Drugs Market - Latin America
    • 8.7.1. Latin America: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.7.4. Antiparasitic Drugs Market - Mexico
      • 8.7.4.1. Mexico: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.7.5. Antiparasitic Drugs Market - Brazil
      • 8.7.5.1. Brazil: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.7.6. Antiparasitic Drugs Market - Argentina
      • 8.7.6.1. Argentina: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AstraZeneca
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Bayer AG
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Cipla Limited
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Dr. Reddy's Laboratories
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. F. Hoffmann-La Roche Ltd
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. GlaxoSmithKline
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Ipca Laboratories Ltd
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Lupin Pharmaceuticals
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Merck & Co.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Novartis
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Pfizer
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Sanofi
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Sun Pharmaceutical Industries Ltd.
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Viatris
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Zydus Group
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development

List of Tables

  • Table 1 Global Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 2 Global Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 3 Global Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 4 Antiparasitic Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 6 North America: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 7 North America: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 8 U.S.: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 10 U.S.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 11 Canada: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 13 Canada: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 14 Europe: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 16 Europe: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 17 UK: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 18 UK: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 19 UK: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 20 France: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 21 France: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 22 France: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 23 Germany: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 25 Germany: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 26 Italy: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 28 Italy: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 29 Spain: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 31 Spain: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 35 Russia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 37 Russia: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 41 China: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 42 China: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 43 China: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 44 India: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 45 India: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 46 India: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 50 Japan: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 52 Japan: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 56 South Korea: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 58 South Korea: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 65 UAE: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 67 UAE: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 68 Israel: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 70 Israel: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 71 South Africa: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 73 South Africa: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 74 Latin America: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 76 Latin America: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 77 Mexico: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 79 Mexico: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 80 Brazil: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 82 Brazil: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 83 Argentina: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 85 Argentina: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Antiparasitic Drugs Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Route of Administration
  • Figure 7. Global Antiparasitic Drugs Market, by Route of Administration, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Type
  • Figure 9. Global Antiparasitic Drugs Market, by Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Antiparasitic Drugs Market, by Distribution Channel, 2022 & 2032 (USD Billion)
  • Figure 12. Antiparasitic Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Antiparasitic Drugs Market